openPR Logo
Press release

Transdermal Drug Delivery Systems Market | Key Player include Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG and Bristol-Myers Squibb Company

10-17-2018 08:09 PM CET | Health & Medicine

Press release from: Allied Market Research

Transdermal Drug Delivery Systems Market | Key Player include

According to a new report published by Allied Market Research, titled, "Transdermal Drug Delivery Systems Market by Type of Delivery System and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global transdermal drug delivery systems market was valued at $ 32,516 million in 2016, and is projected to reach $61,689 million by 2023, growing at a CAGR of 9.5% from 2017 to 2023. The passive system segment held more than three-fifths share of the total market in 2016.

Transdermal drug delivery systems are used to deliver drug through intact skin at a controlled rate into the systemic circulation. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as hypertension, diabetes, and angina, are expected to drive the market growth. Moreover, surge in adoption of new delivery system technologies, such as ultrasound, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.

Download Now! Sample PDF Brochure @ https://www.alliedmarketresearch.com/request-sample/485

The passive system segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of chronic disorders, such as hypertension. The active system segment is expected to register highest CAGR of 12.8% during the forecast period.

Key Findings of the Transdermal Drug Delivery Systems Market:
• Reservoir system segment is projected to grow at a CAGR of 7.3% during the forecast period.
• Matrix system contributed for nearly two-third share of the global passive transdermal drug delivery systems market, in 2016.
• Structure-based drug delivery system segment is expected to register the highest CAGR of 13.3% during the analysis period.
• Cardiovascular disorders segment is expected to grow at the highest CAGR of 10.8% during the forecast period.
• France and Germany collectively contributed for more than one-third share of the European transdermal drug delivery systems market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific transdermal drug delivery systems market in 2016.

Asia-Pacific is projected to register the highest CAGR of 10.1% during the forecast period, owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective technologies in these nations offer a lucrative opportunity for the market growth.

The major companies profiled in the report includes Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.

TABLE OF CONTENT:

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rising geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Rise in adoption of third-generation delivery systems

3.4.2. Restraints

3.4.2.1. Side-effects of the systems

3.4.3. Opportunities

3.4.3.1. Emerging nations

Chapter: 4 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE OF DELIVERY SYSTEM

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PASSIVE DELIVERY SYSTEM

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Matrix delivery system

4.2.3.1.1. Market size and forecast

4.2.3.2. Reservoir delivery system

4.2.3.2.1. Market size and forecast

4.3. ACTIVE DELIVERY SYSTEM

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Structure-based drug delivery system

4.3.3.1.1. Market size and forecast

4.3.3.2. Electrically-based drug delivery system

4.3.3.2.1. Market size and forecast
4.3.3.2.2. Iontophoresis

4.3.3.2.2.1. Market size and forecast

4.3.3.2.3. Electroporation

4.3.3.2.3.1. Market size and forecast

4.3.3.2.4. Sonophoresis

4.3.3.2.4.1. Market size and forecast

4.3.3.3. Other

4.3.3.3.1. Market size and forecast

Chapter: 5 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ANALGESICS

5.2.1. Market size and forecast

5.3. HORMONE REPLACEMENT THERAPY

5.3.1. Market size and forecast

5.4. HYPERTENSION

5.4.1. Market size and forecast

5.5. MOTION SICKNESS

5.5.1. Market size and forecast

5.6. SMOKING CESSATION

5.6.1. Market size and forecast

5.7. OTHERS

5.7.1. Market size and forecast

Chapter: 6 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. ACRUX LIMITED

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)

7.2. BAYER AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)

7.3. BOEHRINGER INGELHEIM GMBH

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)

7.4. BRISTOL-MYERS SQUIBB COMPANY

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)

7.5. ECHO THERAPEUTICS, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)

7.6. ENDO PHARMACEUTICALS INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)

7.7. GLAXOSMITHKLINE PLC

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)

7.8. JOHNSON & JOHNSON

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)

7.9. MYLAN N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)

7.10. NOVARTIS AG

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)

Check offers and discount on this report @ https://www.alliedmarketresearch.com/get-discount/485

About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Drug Delivery Systems Market | Key Player include Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG and Bristol-Myers Squibb Company here

News-ID: 1311235 • Views:

More Releases from Allied Market Research

Graphene Electronics Market With in-detailed Competitor Analysis, Forecast to 2032
Graphene Electronics Market With in-detailed Competitor Analysis, Forecast to 20 …
Allied Market Research published an exclusive report, titled, "Graphene Electronics Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, By Industry Vertical : Global Opportunity Analysis and Industry Forecast, 2021-2031". The global graphene electronics market was valued at $270.8 million in 2021, and is projected to reach $5.2 billion by 2031, growing at a CAGR of 34.2% from 2022 to 2031 Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/142 The graphene
Lithium-Ion Battery Energy Storage System Market Size is projected to reach $17.1 billion by 2031 | Jakson Group, LG Electronics
Lithium-Ion Battery Energy Storage System Market Size is projected to reach $17. …
Allied Market Research published an exclusive report, titled, "Lithium-Ion Battery Energy Storage System Market Size, Share, Competitive Landscape and Trend Analysis Report by Connection Type, by Application : Global Opportunity Analysis and Industry Forecast, 2021-2031". The global lithium-ion battery energy storage system market was valued at $4.5 billion in 2021, and is projected to reach $17.1 billion by 2031, growing at a CAGR of 15% from 2022 to 2031. Download Research Report
Smart Railway Market Poised for Remarkable Growth, Reaching $38,469.7 million by 2027
Smart Railway Market Poised for Remarkable Growth, Reaching $38,469.7 million by …
𝐒𝐦𝐚𝐫𝐭 𝐑𝐚𝐢𝐥𝐰𝐚𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 by System (Passenger Information System, Rail & Freight Operations Management System, Smart Safety & Security Monitoring System, Rail communication & Networking System, Smart Ticketing System, Rail Analytics System, and Others) and Offering Type (Solutions, Components & Devices, and Services): Global Opportunity Analysis and Industry Forecast, 2020-2027" According to the report published by Allied Market Research, The global smart railway market size was valued at $18,304.8 million in
Odor Sensor Market Size is projected to reach $19.4 billion by 2031 | eNose Company, Odotech
Odor Sensor Market Size is projected to reach $19.4 billion by 2031 | eNose Comp …
Allied Market Research published an exclusive report, titled, "Odor Sensor Market Size, Share, Competitive Landscape and Trend Analysis Report by Sensor Type, by Instrument Type, by Application Areas, by End Use Industry : Global Opportunity Analysis and Industry Forecast, 2021-2031". The global odor sensor market size was valued at $1.5 billion in 2021, and is projected to reach $19.4 billion by 2031, growing at a CAGR of 29.4% from 2022 to

All 5 Releases


More Releases for Key

Marine Radio Market Key Vendors, Key Segment, Key Companies, Growth Opportunitie …
The demand for broadband connections, mobile satellite services, mobile satellite communications, and very-small-aperture terminal (VSAT) connectivity worldwide are all expected to increase over the forecast period, which will benefit the global marine communication market. Various applications, including fishing boats and vessels, merchant ships, recreational boats, working boats, and others, are catered to by marine communication solutions. Demand is anticipated to increase in the coming years due to the growing need
Smartwatch Market Key Trends, Key Segment, Key Demand and Forecast 2031
Global Smartwatch Market: Snapshot Smart watches are touted as next generation wearable device as they gradually eat into the market share of their indigenous counterparts. With rapid advances in technology and nonstop innovations, smartwatches pose significant threat to personal devices and watches industries. Furthermore, with the advent of 3G and 4G enabled smartwatches, which are available in varying watch faces, has stoked their salability. Furthermore, breakthroughs in artificial intelligence, meaning learning, and
Bluetooth Speakers Market Size And Forecast | Key Player I, Key Player II, Key P …
New Jersey, United States - The research study offers an in-depth assessment of the Bluetooth Speakers Market and helps market players to gain a foothold in the industry. It highlights critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for the challenges ahead. It provides a regional analysis of the Bluetooth Speakers market to uncover major opportunities available in different parts of the world. The
Smart Governments Market Size And Forecast | Key Player I, Key Player II, Key Pl …
New Jersey, United States - The research study offers an in-depth assessment of the Smart Governments Market and helps market players to gain a foothold in the industry. It highlights critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for the challenges ahead. It provides a regional analysis of the Smart Governments market to uncover major opportunities available in different parts of the world. The
USA Identity & Access Management Market Size And Forecast | Key Player I, Key Pl …
New Jersey, United States - The research study offers an in-depth assessment of the USA Identity & Access Management Market and helps market players to gain a foothold in the industry. It highlights critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for the challenges ahead. It provides a regional analysis of the USA Identity & Access Management market to uncover major opportunities available in
Biobanks Market Key Trends, Key Segment, Key Demand and Forecast 2025
Global Biobanks Market: Overview The global biobanks market owes its conception to the rising need for replacement organs and the steady advancement in the replacement and transfusion technologies regarding a number of bodily substances. Though the technology and need to store organs and other bio-entities had been available for a long time, the global biobanks market took on a more important role in the healthcare sector following the increasing research in